Research Interests
Perinatal infection, maternal immunization, preterm birth, disparities in maternal health
Selected Grants
Duke University Maternal-Fetal Medicine Units (MFMU) Network Clinical Center
ResearchCo Investigator · Awarded by Eunice Kennedy Shriver National Institute of Child Health and Human Development · 2023 - 2030CISA 2023 Clinical Contributing Task 1
ResearchInvestigator · Awarded by Centers for Disease Control and Prevention · 2023 - 2028CISA 2023 Clinical Contributing Task 2
ResearchInvestigator · Awarded by Centers for Disease Control and Prevention · 2023 - 2028CISA 2023-03 Task 3 Lead - HAI assays
ResearchPrincipal Investigator · Awarded by Centers for Disease Control and Prevention · 2023 - 2026CISA 2023-03 Task 2 Lead - Single IRB work
ResearchPrincipal Investigator · Awarded by Centers for Disease Control and Prevention · 2023 - 2026CISA 2023-03 Task 4 Lead - COVID immunogenicity
ResearchPrincipal Investigator · Awarded by Centers for Disease Control and Prevention · 2023 - 2026CISA 2023-03 Task 1 Lead - Enrollment/Follow up
ResearchPrincipal Investigator · Awarded by Centers for Disease Control and Prevention · 2023 - 2026Testing a Clinician and Patient Intervention to Promote smoking Cessation Among Pregnant Women
ResearchCo Investigator · Awarded by National Institutes of Health · 2021 - 2026Population Health Research Support IDIQ Base
Clinical TrialInvestigator · Awarded by National Institutes of Health · 2018 - 2025ADEPT - An adaptive prenatal intervention to increase childhood vaccinations
ResearchCo Investigator · Awarded by Emory University · 2022 - 2025Duke Women's Reproductive Health Research Scholars
Inst. Training Prgm or CMEMentor · Awarded by Eunice Kennedy Shriver National Institute of Child Health and Human Development · 2020 - 2025CISA Maternal COVID Immunogenicity
ResearchPrincipal Investigator · Awarded by Centers for Disease Control and Prevention · 2022 - 20242020 CISA 04-COVID Maternal Study
ResearchPrincipal Investigator · Awarded by Centers for Disease Control and Prevention · 2020 - 2024Duke CTSA (TL1) Year 5
Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2018 - 2024CISA Consult 2022 Contributing Task 3
Clinical TrialInvestigator · Awarded by Centers for Disease Control and Prevention · 2022 - 2023CISA Consult 2022 Contributing Task 2
ResearchPrincipal Investigator · Awarded by Centers for Disease Control and Prevention · 2022 - 2023Vaccine and Treatment Evaluation Units (VTEU)
ResearchInvestigator · Awarded by National Institutes of Health · 2013 - 2023Pulmonary Complications in a Brith Cohort after a Randomized Trial of Exposure to Antenatal Corticosteroids: the ALPS Follow-Up Study Capitation
ResearchPrincipal Investigator · Awarded by The George Washington University · 2016 - 2023VTEU TO #132 Base - Task Area A - FY.2020.A1B1C1D1.0123 - Option 2.A
ResearchCo-Principal Investigator · Awarded by National Institutes of Health · 2021 - 2023VTEU HHSN272201300017I/75N93019F00132-FY2020.A1B1C1D1.0123 Task Order #17 16-0076 Task C Option 3 & Task D Option 6 Extension
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2021 - 2022CISA 2021-2022- Clinical Consult CLIN 4002 - Optional Task 1, Option Year 4
ResearchPrincipal Investigator · Awarded by Centers for Disease Control and Prevention · 2020 - 2022CISA 2018-2019- Clinical Consult - Opt 1
ResearchPrincipal Investigator · Awarded by Centers for Disease Control and Prevention · 2017 - 2022RTOP 2018 CISA 01 Flublok Lead Task 3
ResearchPrincipal Investigator · Awarded by Centers for Disease Control and Prevention · 2020 - 2022RTOP 2018 CISA 01 Flublok Lead Task 4
ResearchPrincipal Investigator · Awarded by Centers for Disease Control and Prevention · 2020 - 2022RTOP 2018 CISA 01 Flublok Lead Task 2
ResearchPrincipal Investigator · Awarded by Centers for Disease Control and Prevention · 2020 - 2022RTOP 2018 CISA 01 Flublok Lead Task 1
ResearchPrincipal Investigator · Awarded by Centers for Disease Control and Prevention · 2018 - 2022RTOP 2018 CISA 01 Flublok Lead Base
ResearchPrincipal Investigator · Awarded by Centers for Disease Control and Prevention · 2018 - 2022"An adaptive prenatal (ADEPT) intervention to encourage childhood vaccinations
ResearchCo Investigator · Awarded by Centers for Disease Control and Prevention · 2021 - 2022Pulmonary Complications in a Birth Cohort after a Randomized Trial of Exposure to Antenatal Corticosteroids: the ALPS Follow-Up Study
ResearchPrincipal Investigator · Awarded by The George Washington University · 2016 - 2022Affecting Culture Change: Building Unit-Level Infrastructure to Mitigate Research Integrity Risk
Institutional SupportPrincipal Investigator · Awarded by Department of Health and Human Services · 2020 - 2021Adaptive COVID-19 Treatment Trial (ACTT)
ResearchInvestigator · Awarded by Leidos Biomedical Research, Inc. · 2020 - 2021VTEU Task Area A - FY.2020.A1B1C1D1.0123 - Option 1
ResearchCo-Principal Investigator · Awarded by National Institutes of Health · 2020 - 2021UNC-Duke Collaborative Clinical Pharmacology Postdoctoral Training Program
Inst. Training Prgm or CMEMentor · Awarded by University of North Carolina - Chapel Hill · 2020 - 2021VTEU Task Area C Option 2-3 Protocol 15-0020.B1C1.0040
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2019 - 2021VTEU Protocol Implementation Option 1
ResearchInvestigator · Awarded by National Institutes of Health · 2019 - 2021The relationship between maternal ZIKV-specific and ADE antibodies and fetal outcome
ResearchCo-Principal Investigator · Awarded by National Institutes of Health · 2018 - 2021MFMU Network Study - ALPS FSN
Clinical TrialPrincipal Investigator · Awarded by University of North Carolina - Chapel Hill · 2018 - 2021NICHD Maternal Fetal Medicine Units Network
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2011 - 2021VTEU Task Area A - FY.2020.A1B1C1D1.0123 - Base-A
ResearchCo-Principal Investigator · Awarded by National Institutes of Health · 2019 - 2020VTEU Task Area A - FY.2020.A1B1C1D1.0123 - Base
ResearchCo-Principal Investigator · Awarded by National Institutes of Health · 2019 - 2020Rapid, Near Patient Nucleic Acid Testing for Infant Cytomegalovirus (CMV) Infection
ResearchCollaborator · Awarded by Baebies, Inc · 2017 - 2020RSV- M-301
Clinical TrialPrincipal Investigator · Awarded by Novavax, Inc. · 2015 - 2020VTEU Task Area C Option 2-2 Protocol 15-0020.B1C1.0040
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2018 - 2020VTEU RTOP FY.2019.A1B1C1D1.0103 - Task A - Base
ResearchCo-Principal Investigator · Awarded by National Institutes of Health · 2018 - 2019MFMU Network Studies
Clinical TrialPrincipal Investigator · Awarded by George Washington University · 2013 - 2018CISA: 2015 CISA 03 - Lead Site Base Task: Maternal Tdap and IIV Study (Lead)
Clinical TrialPrincipal Investigator · Awarded by Centers for Disease Control and Prevention · 2015 - 2018Duke Research Training Program for Pediatricians
Inst. Training Prgm or CMETraining Faculty · Awarded by National Institutes of Health · 2002 - 2018Duke CTSA (UL1)
ResearchInvestigator · Awarded by National Institutes of Health · 2013 - 2018RSV-M-203: Study M-203 - A Phase II Randomized, Observer-blind, Placebo-Controlled, Study to Evaluate the Safety and Immunogenicity of a Respiratory Syncytial Virus (RSV) Fusion (F)
Clinical TrialPrincipal Investigator · Awarded by Novavax, Inc. · 2014 - 2017CISA Task Order No. 3 Tdap Safety in Pregnant Women
ResearchPrincipal Investigator · Awarded by Centers for Disease Control and Prevention · 2013 - 2016A Phase II, Multicenter, Randomized, Observer-Blind, Controlled Study to Evaluate Safety and Immunogenicity of a Trivalent Group B Streptococcus Vaccine in Healthy Pregnant Women
Clinical TrialPrincipal Investigator · Awarded by Novartis Vaccines and Diagnostics, Inc · 2013 - 2015SAFETY AND IMMUNOGENICITY OF TDAP VACCINE IN HEALTHY PREGNANT WOMEN, SAFETY IN THEIR NEONATES, AND EFFECT OF MATERNAL IMMUNIZATION ON INFANT IMMUNE RESPONSES TO DTAP VACCINE - DMID 05-0048
ResearchPrincipal Investigator · Awarded by University of Maryland · 2010 - 2012DMID 09-0005 Safety and Immunogenicity
Clinical TrialPrincipal Investigator · Awarded by University of Maryland · 2010 - 2012Effectiveness of a Vaccination Program in the Community ObGyn Setting
ResearchPrincipal Investigator · Awarded by Centers for Disease Control and Prevention · 2008 - 201109-0056 A Phase II Study in Pregnant Women to Assess the Safety and Immunogenicity of an Unadjuvanted Sanofi Pasteur H1N1 Inactivated Influenza Vaccine Administered at Two Dose Levels
Clinical TrialPrincipal Investigator · Awarded by University of Maryland · 2009 - 2010A randomized double-blind trial on the safety and immunogenicity of inactivated trivalent influenza vaccine in pregnant women.
ResearchPrincipal Investigator · Awarded by University of Maryland · 2009 - 2010Prevention of Influenza in Infants by Immunization of Their Contacts in the Household (PIIITCH study)
ResearchCo-Principal Investigator · Awarded by Centers for Disease Control and Prevention · 2006 - 2009Fellowships, Gifts, and Supported Research
Relationship Between Maternal Humoral Immunity and Fetal Outcome of Maternal Zika Virus Infection ·
September 1, 2017
- August 31, 2018
Co-Principal Investigator ·
Awarded by: Duke University & Duke-National University of Singapore
· $200,000.00
External Relationships
- American College of Ob-Gyn
- Dynavax Technologies Corporation
- Medscape ( WebMD HLTH Corp.)
- Moderna Therapeutics, Inc.
- Northwell Health
- Pfizer Inc.
- Sanofi
- UpToDate, Inc
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.